Form 10 Explorer
10-Q
Quarterly Report
VITASPRING BIOMEDICAL CO., LTD.

CIK: 1697884

File #: 333-216645

Period End: Jul 31, 2024

Fiscal Year: 2025

View on EDGAR
Balance Sheet
28 line items · 2 periods
XBRL
ItemJul 31, 2024Jan 31, 2024
BALANCE SHEETS
ASSETS
CURRENT ASSETS
Cash
5,52513
Other Non-Operating Current Assets
39,7250
Other Current Assets
023,614
Total current assets
45,25023,627
LONG-TERM ASSETS
Property, Plant and Equipment
19,08424,063
Operating Lease Right-of-Use Asset
089,652
Total long-term assets
19,084113,715
Total assets
64,334137,342
LIABILITIES AND STOCKHOLDERS' DEFICIT
CURRENT LIABILITIES
Accounts Payable
2,411,0002,411,000
Other Non-Operating Current Liabilities
364,433339,001
Taxes Payable
218,714218,714
Operating Lease Liability, Current
093,334
Advances from related party
773,436425,482
Total current liabilities
3,767,5833,487,531
Total liabilities
3,767,5833,487,531
COMMITMENTS AND CONTINGENCIES
00
STOCKHOLDERS' DEFICIT
Total Stockholders' Equity
20,70320,703
Total Stockholders' Equity
1,218,1221,135,689
Total Stockholders' Equity
(4,942,074)(4,506,581)
Total stockholders' deficit
(3,703,249)(3,350,189)
Total liabilities and stockholders' deficit
64,334137,342